Insights

Expansion into Ireland Astellas recently expanded its facilities to Ireland in September 2023 with a €330 million state-of-the-art facility construction in Tralee. This expansion indicates a growing presence and potential business opportunities in the region.

Digital Health Offering in the US Astellas has launched its first digital health offering in the US, providing a toolkit for at-home monitoring for individuals living with heart failure. This offering opens up opportunities for partnerships with healthcare providers and insurers in the digital health space.

Partnership with Mydohc Astellas partnered with Mydohc and announced Desert Oasis Healthcare as the first health system to implement DIGITIVA(TM) for heart failure management. This collaboration presents possibilities for further collaborations with healthcare organizations and systems.

Investment in AviadoBio Limited Astellas invested $30 million into AviadoBio Limited, a London-based company. This financial investment showcases Astellas' interest in innovative biotech solutions and signifies potential future collaborations or acquisitions in the biotech sector.

Closure of Offices in South San Francisco Astellas closed its offices in South San Francisco, California, and a gene therapy manufacturing facility. This strategic move may lead to opportunities to reallocate resources and focus on optimizing operations in other locations or exploring new partnerships in different regions.

Astellas Pharma Tech Stack

Astellas Pharma uses 8 technology products and services including Simulink, SAS/GRAPH, QlikView, and more. Explore Astellas Pharma's tech stack below.

  • Simulink
    Advanced Analytics And Data Science
  • SAS/GRAPH
    Business Intelligence
  • QlikView
    Business Intelligence
  • Varnish
    Caching
  • jsDelivr
    Content Delivery Network
  • AMS
    E-commerce Platforms
  • Oracle ERP
    Enterprise
  • Apache
    Web Servers

Media & News

Astellas Pharma's Email Address Formats

Astellas Pharma uses at least 1 format(s):
Astellas Pharma Email FormatsExamplePercentage
First.Last@astellas.comJohn.Doe@astellas.com
95%
First_Last@astellas.comJohn_Doe@astellas.com
3%
FLast@astellas.comJDoe@astellas.com
1%
First-Last@astellas.comJohn-Doe@astellas.com
1%

Frequently Asked Questions

Where is Astellas Pharma's headquarters located?

Minus sign iconPlus sign icon
Astellas Pharma's main headquarters is located at 2-5-1, Nihonbashi-Honcho Chuo-Ku, Tokyo 103-8411 JP. The company has employees across 6 continents, including AsiaNorth AmericaEurope.

What is Astellas Pharma's official website and social media links?

Minus sign iconPlus sign icon
Astellas Pharma's official website is astellas.com and has social profiles on LinkedIn.

How much revenue does Astellas Pharma generate?

Minus sign iconPlus sign icon
As of October 2024, Astellas Pharma's annual revenue reached $5B.

What is Astellas Pharma's SIC code NAICS code?

Minus sign iconPlus sign icon
Astellas Pharma's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 424210 - Drugs and Druggists' Sundries Merchant Wholesalers.

How many employees does Astellas Pharma have currently?

Minus sign iconPlus sign icon
As of October 2024, Astellas Pharma has approximately 10K employees across 6 continents, including AsiaNorth AmericaEurope. Key team members include Chief Executive Officer: D. P.Chief Executive Officer: D. P.Chief Digital & Transformation Officer (cdto), Executive Committee Member: N. E.. Explore Astellas Pharma's employee directory with LeadIQ.

What industry does Astellas Pharma belong to?

Minus sign iconPlus sign icon
Astellas Pharma operates in the Pharmaceutical Manufacturing industry.

What technology does Astellas Pharma use?

Minus sign iconPlus sign icon
Astellas Pharma's tech stack includes SimulinkSAS/GRAPHQlikViewVarnishjsDelivrAMSOracle ERPApache.

What is Astellas Pharma's email format?

Minus sign iconPlus sign icon
Astellas Pharma's email format typically follows the pattern of . Find more Astellas Pharma email formats with LeadIQ.
Astellas Pharma

Astellas Pharma

Pharmaceutical ManufacturingTokyo, Japan10001+ Employees

At Astellas, we strive to be a cutting-edge, value-driven life science innovator. This means working at the forefront of healthcare change to turn innovative science into the best outcomes for patients. Operating in approximately 70 countries with more than 14,000 employees, we are relentless in our pursuit of scientific progress and in tackling unmet medical needs. Visit our Global Astellas LinkedIn Community Guidelines to learn more about interacting with this page: https://www.astellas.com/en/global-linkedin-community-guidelines

Section iconCompany Overview

Headquarters
2-5-1, Nihonbashi-Honcho Chuo-Ku, Tokyo 103-8411 JP
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
Employees
10001+

Section iconFunding & Financials

  • $1B

    Astellas Pharma's revenue is in the range of $1B

Section iconFunding & Financials

  • $1B

    Astellas Pharma's revenue is in the range of $1B

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.